CIK: 0001606074
Total reported value
$1.2B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | NGMUSD | Ngm Biopharmaceuticals INC | Stock-Other | 36.26% | -5.84% | +1.57% | |
| 2 | CNST | Constellation Pharmaceutical | Stock-Other | 33.81% | -5.21% | — | |
| 3 | ✓ | Rapt Therapeutics INC | Stock-Other | 22.34% | -1.66% | — | |
| 4 | RCUS | Arcus Biosciences INC | Stock-Other | 4.27% | -3.66% | EXIT | |
| 5 | 2JQ | Gritstone Bio INC | Stock-Other | 3.32% | -0.75% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CNST | Constellation Pharmaceutical | +21.7% | — | Unchanged |
| 2 | 2JQ | Gritstone Bio INC | -5% | — | Unchanged |
| 3 | RCUS | Arcus Biosciences INC | -5.7% | — | Unchanged |
| 4 | NGMUSD | Ngm Biopharmaceuticals INC | -33.3% | +1.57% | Add |
| 5 | ✓ | Rapt Therapeutics INC | — | NEW | New buy |